Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Receivables (2020 - 2026)

Trulieve Cannabis has reported Receivables over the past 6 years, most recently at $10.5 million for Q4 2025.

  • For Q4 2025, Receivables rose 26.65% year-over-year to $10.5 million; the TTM value through Dec 2025 reached $10.5 million, up 26.65%, while the annual FY2025 figure was $10.5 million, 26.65% up from the prior year.
  • Receivables for Q4 2025 was $10.5 million at Trulieve Cannabis, roughly flat from $10.5 million in the prior quarter.
  • Over five years, Receivables peaked at $29.5 million in Q2 2023 and troughed at $2.6 million in Q1 2021.
  • A 5-year average of $11.7 million and a median of $10.1 million in 2023 define the central range for Receivables.
  • Biggest five-year swings in Receivables: soared 2728.75% in 2021 and later plummeted 76.89% in 2023.
  • Year by year, Receivables stood at $8.9 million in 2021, then soared by 227.6% to $29.0 million in 2022, then plummeted by 76.89% to $6.7 million in 2023, then rose by 23.65% to $8.3 million in 2024, then grew by 26.65% to $10.5 million in 2025.
  • Business Quant data shows Receivables for TCNNF at $10.5 million in Q4 2025, $10.5 million in Q3 2025, and $10.8 million in Q2 2025.